Jim Cramer was asked about Netherlands-based immuno-oncology company Merus NV (NASDAQ:MRUS) on CNBC. Cramer said the stock is speculative. “This is one of those things that may not work out.

CNBC's Jim Cramer reviewed Monday's market action and gave his take on why a large swath of stocks are notching losses, focusing on bruised sectors like consumer goods. He suggested that the power ...

Jim Cramer in a program on CNBC in late October recommended investors to “buy, buy, buy” Crowdstrike Holdings Inc (NASDAQ:CRWD). Cramer praised the company’s CEO George Kurtz. Cramer said ...

As Deutsche Bank strategist Henry Allen notes, large stock market declines without a recession are infrequent, but not ...

© 2025 The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

A Wall Street veteran resets his Microsoft forecast.

There are proposals on the table at the 69th Montana Legislature to reallocate marijuana tax revenue for uses aside from the ...

The Palisades Fire — one of five wildfires threatening the Los Angeles area — is the most destructive fire in the county’s history. It remains 0% contained.

The law that could ban TikTok is coming before the Supreme Court. The justices largely hold the app’s fate in their hands as ...

Advanced Micro Devices shows bearish near-term signals but strong growth ahead. Learn why AMD stock could be an attractive ...

Jim Pillen, a former University of Nebraska defensive ... his recovery at hospitals in Columbus and Omaha and getting back to work in a sit-down interview with the Nebraska Examiner on Friday.